SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India
- PMID: 33929947
- DOI: 10.12788/jhm.3609
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India
Abstract
Background: SARS-CoV-2 infection (COVID-19) poses a tremendous challenge to healthcare systems across the globe. Serologic testing for SARS-CoV-2 infection in healthcare workers (HCWs) may quantify the rate of clinically significant exposure in an institutional setting and identify those HCWs who are at greatest risk.
Methods: We conducted a survey and SARS-CoV-2 serologic testing among a convenience sample of HCWs from 79 non-COVID and 3 dedicated COVID hospitals in District Srinagar of Kashmir, India. In addition to testing for the presence of SARS-CoV-2-specific immunoglobulin G (IgG), we collected information on demographics, occupational group, influenza-like illness (ILI) symptoms, nasopharyngeal reverse transcription polymerase chain reaction (RT-PCR) testing status, history of close unprotected contacts, and quarantine/travel history.
Results: Of 7,346 eligible HCWs, 2,915 (39.7%) participated in the study. The overall prevalence of SARS-CoV-2-specific IgG antibodies was 2.5% (95% CI, 2.0%-3.1%), while HCWs who had ever worked at a dedicated COVID-19 hospital had a substantially lower seroprevalence of 0.6% (95% CI, 0.2%-1.9%). Higher seroprevalence rates were observed among HCWs who reported a recent ILI (12.2%), a positive RT-PCR (27.6%), a history of being put under quarantine (4.9%), and a history of close unprotected contact with a person with COVID-19 (4.4%). Healthcare workers who ever worked at a dedicated COVID-19 hospital had a lower multivariate-adjusted risk of seropositivity (odds ratio, 0.21; 95% CI, 0.06-0.66).
Conclusions: Our investigation suggests that infection-control practices, including a compliance-maximizing buddy system, are valuable and effective in preventing infection within a high-risk clinical setting. Universal masking, mandatory testing of patients, and residential dormitories for HCWs at COVID-19-dedicated hospitals is an effective multifaceted approach to infection control. Moreover, given that many infections among HCWs are community-acquired, it is likely that the vigilant practices in these hospitals will have spillover effects, creating ingrained behaviors that will continue outside the hospital setting.
Similar articles
-
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021. PLoS One. 2021. PMID: 33793673 Free PMC article.
-
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.Indian J Med Res. 2021 Jan & Feb;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20. Indian J Med Res. 2021. PMID: 33642348 Free PMC article.
-
Source and symptoms of COVID-19 among hospital workers in Milan.Occup Med (Lond). 2020 Dec 30;70(9):672-679. doi: 10.1093/occmed/kqaa201. Occup Med (Lond). 2020. PMID: 33269398 Free PMC article.
-
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16. J Hosp Infect. 2021. PMID: 33212126 Free PMC article.
-
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8. Clin Microbiol Infect. 2021. PMID: 34116205 Free PMC article.
Cited by
-
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.J Clin Nurs. 2022 Jun;31(11-12):1557-1569. doi: 10.1111/jocn.16009. Epub 2021 Sep 27. J Clin Nurs. 2022. PMID: 34570947 Free PMC article.
-
A multi-site cross-sectional study on the burden of SARS-CoV-2 in healthcare workers in Madagascar.PLoS One. 2024 Oct 24;19(10):e0309977. doi: 10.1371/journal.pone.0309977. eCollection 2024. PLoS One. 2024. PMID: 39446732 Free PMC article.
-
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.Int J Infect Dis. 2022 Mar;116:59-67. doi: 10.1016/j.ijid.2021.12.353. Epub 2021 Dec 28. Int J Infect Dis. 2022. PMID: 34968773 Free PMC article.
-
Immunoglobulin-G Antibodies against Severe Acute Respiratory Syndrome - Coronavirus-2 among Health-Care Workers: A Serosurveillance Study from India.Int J Appl Basic Med Res. 2022 Jan-Mar;12(1):18-23. doi: 10.4103/ijabmr.ijabmr_516_21. Epub 2022 Jan 31. Int J Appl Basic Med Res. 2022. PMID: 35265476 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.BMJ Open. 2021 Sep 23;11(9):e053791. doi: 10.1136/bmjopen-2021-053791. BMJ Open. 2021. PMID: 34556519 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous